|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 527.8 CHF | +2.72% |
|
+4.97% | +49.22% |
| Apr. 18 | Global markets live: DocMorris, Microsoft, Oracle, Micron, Netflix... |  |
| Apr. 18 | Lonza Finance Launches EUR1 Billion 12-Year Euro Bond | DJ |
ZURICH (Reuters) - Swiss contract drug manufacturer Lonza said on Wednesday it has signed an agreement to acquire the Genentech manufacturing facility in Vacaville, California, from drugmaker Roche for $1.2 billion in cash.
Lonza plans to invest around 500 million Swiss francs ($562.30 million) to upgrade the facility and enhance capabilities at the site to accommodate the next generation of mammalian biologics therapies, the company said in a statement.
($1 = 0.8892 Swiss francs)
(Reporting by Dave Graham; Editing by Miranda Murray)
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 527.8 CHF | +2.72% | +4.97% | 41.61B | ||
| 221 CHF | +1.01% | -0.50% | 195B | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +49.22% | 41.61B | |
| +1.51% | 42.75B | |
| +8.57% | 41.34B | |
| -12.36% | 26.59B | |
| +8.92% | 25.49B | |
| -25.13% | 18.12B | |
| +29.17% | 12.24B | |
| -3.12% | 11.76B | |
| +6.35% | 11B | |
| -16.98% | 10.07B |
LONZA GROUP AG 
